nodes	percent_of_prediction	percent_of_DWPC	metapath
Aclidinium—Tiotropium—SLC22A4—Crohn's disease	0.16	0.571	CrCbGaD
Aclidinium—Tiotropium—SLC22A5—Crohn's disease	0.12	0.429	CrCbGaD
Aclidinium—CHRM3—muscle of abdomen—Crohn's disease	0.0706	0.498	CbGeAlD
Aclidinium—CHRM5—epithelium—Crohn's disease	0.015	0.106	CbGeAlD
Aclidinium—CHRM5—skin of body—Crohn's disease	0.0143	0.101	CbGeAlD
Aclidinium—CHRM3—smooth muscle tissue—Crohn's disease	0.00809	0.0572	CbGeAlD
Aclidinium—BCHE—smooth muscle tissue—Crohn's disease	0.00661	0.0467	CbGeAlD
Aclidinium—BCHE—skin of body—Crohn's disease	0.00652	0.0461	CbGeAlD
Aclidinium—CHRM3—digestive system—Crohn's disease	0.00639	0.0451	CbGeAlD
Aclidinium—BCHE—mammalian vulva—Crohn's disease	0.00595	0.042	CbGeAlD
Aclidinium—BCHE—digestive system—Crohn's disease	0.00522	0.0368	CbGeAlD
Aclidinium—BCHE—lymph node—Crohn's disease	0.00298	0.021	CbGeAlD
Aclidinium—CHRM1—GPCR ligand binding—CCR6—Crohn's disease	0.00136	0.00235	CbGpPWpGaD
Aclidinium—CHRM3—GPCR ligand binding—CCR6—Crohn's disease	0.00135	0.00234	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—ACKR2—Crohn's disease	0.00134	0.00232	CbGpPWpGaD
Aclidinium—CHRM2—GPCR ligand binding—CCR6—Crohn's disease	0.00134	0.00231	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—MLN—Crohn's disease	0.00133	0.0023	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—MLN—Crohn's disease	0.00127	0.0022	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—PLA2G4F—Crohn's disease	0.00127	0.0022	CbGpPWpGaD
Aclidinium—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	0.00126	0.00219	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—TAGAP—Crohn's disease	0.00121	0.0021	CbGpPWpGaD
Aclidinium—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	0.00121	0.00209	CbGpPWpGaD
Aclidinium—CHRM1—GPCR ligand binding—PTGER4—Crohn's disease	0.00119	0.00206	CbGpPWpGaD
Aclidinium—CHRM3—GPCR ligand binding—PTGER4—Crohn's disease	0.00119	0.00206	CbGpPWpGaD
Aclidinium—CHRM2—GPCR ligand binding—PTGER4—Crohn's disease	0.00118	0.00204	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—TAGAP—Crohn's disease	0.00116	0.00201	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—CCR9—Crohn's disease	0.00116	0.002	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—CCR9—Crohn's disease	0.00115	0.00199	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—CCR9—Crohn's disease	0.00114	0.00197	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—CCR6—Crohn's disease	0.00114	0.00197	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—CCR6—Crohn's disease	0.00109	0.00188	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—MTMR3—Crohn's disease	0.00108	0.00187	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—GPR65—Crohn's disease	0.00107	0.00186	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—GPR65—Crohn's disease	0.00107	0.00185	CbGpPWpGaD
Aclidinium—CHRM4—G alpha (i) signalling events—CXCL8—Crohn's disease	0.00107	0.00185	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—GPR65—Crohn's disease	0.00106	0.00184	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—RSPO3—Crohn's disease	0.00106	0.00184	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—CCR9—Crohn's disease	0.00105	0.00182	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—CCR9—Crohn's disease	0.00105	0.00181	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—CCR9—Crohn's disease	0.00104	0.00179	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—CCR6—Crohn's disease	0.00103	0.00178	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—RSPO3—Crohn's disease	0.00102	0.00176	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—SEL1L—Crohn's disease	0.00101	0.00174	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—PTGER4—Crohn's disease	0.001	0.00173	CbGpPWpGaD
Aclidinium—CHRM2—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	0.000988	0.00171	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—CCR6—Crohn's disease	0.000988	0.00171	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—GPR65—Crohn's disease	0.000976	0.00169	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—PLA2G4F—Crohn's disease	0.000976	0.00169	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—GPR65—Crohn's disease	0.000973	0.00168	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—GPR65—Crohn's disease	0.000964	0.00167	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—SEL1L—Crohn's disease	0.000963	0.00167	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—PTGER4—Crohn's disease	0.000958	0.00166	CbGpPWpGaD
Aclidinium—CHRM2—SIDS Susceptibility Pathways—IL1B—Crohn's disease	0.000948	0.00164	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—ACKR2—Crohn's disease	0.000944	0.00163	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—ACKR2—Crohn's disease	0.000941	0.00163	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—ACKR2—Crohn's disease	0.000932	0.00161	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CCR9—Crohn's disease	0.00092	0.00159	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—PTGER4—Crohn's disease	0.000908	0.00157	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—MLN—Crohn's disease	0.000895	0.00155	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—MLN—Crohn's disease	0.000892	0.00154	CbGpPWpGaD
Aclidinium—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	0.00089	0.00154	CbGpPWpGaD
Aclidinium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	0.000887	0.00153	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—MLN—Crohn's disease	0.000883	0.00153	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CCR9—Crohn's disease	0.000881	0.00152	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—PTGER4—Crohn's disease	0.00087	0.0015	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—GPR65—Crohn's disease	0.000855	0.00148	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—IL3—Crohn's disease	0.000852	0.00147	CbGpPWpGaD
Aclidinium—CHRM4—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000851	0.00147	CbGpPWpGaD
Aclidinium—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	0.000849	0.00147	CbGpPWpGaD
Aclidinium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	0.000846	0.00146	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—FADS1—Crohn's disease	0.00084	0.00145	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—MTMR3—Crohn's disease	0.00083	0.00144	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000824	0.00143	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—GPR65—Crohn's disease	0.000819	0.00142	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—TAGAP—Crohn's disease	0.000818	0.00142	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—TAGAP—Crohn's disease	0.000816	0.00141	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—IL3—Crohn's disease	0.000816	0.00141	CbGpPWpGaD
Aclidinium—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000814	0.00141	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—TAGAP—Crohn's disease	0.000808	0.0014	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000789	0.00137	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—GPX4—Crohn's disease	0.000787	0.00136	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—IL3—Crohn's disease	0.000773	0.00134	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—CCR6—Crohn's disease	0.000766	0.00133	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—CCR6—Crohn's disease	0.000763	0.00132	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—GCKR—Crohn's disease	0.00076	0.00132	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—CCR6—Crohn's disease	0.000756	0.00131	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—RASGRP1—Crohn's disease	0.000748	0.00129	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—IL3—Crohn's disease	0.000741	0.00128	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—RASGRP1—Crohn's disease	0.000716	0.00124	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—RSPO3—Crohn's disease	0.000715	0.00124	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—RSPO3—Crohn's disease	0.000713	0.00123	CbGpPWpGaD
Aclidinium—CHRM2—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000712	0.00123	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—RSPO3—Crohn's disease	0.000706	0.00122	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—CCR6—Crohn's disease	0.000695	0.0012	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—CCR6—Crohn's disease	0.000693	0.0012	CbGpPWpGaD
Aclidinium—CHRM2—SIDS Susceptibility Pathways—TNF—Crohn's disease	0.000688	0.00119	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—CCR6—Crohn's disease	0.000687	0.00119	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—SEL1L—Crohn's disease	0.000678	0.00117	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—SEL1L—Crohn's disease	0.000676	0.00117	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—PTGER4—Crohn's disease	0.000674	0.00117	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—PTGER4—Crohn's disease	0.000672	0.00116	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—SEL1L—Crohn's disease	0.000669	0.00116	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—PTGER4—Crohn's disease	0.000666	0.00115	CbGpPWpGaD
Aclidinium—CHRM4—GPCR ligand binding—CXCL8—Crohn's disease	0.000648	0.00112	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—FADS1—Crohn's disease	0.000646	0.00112	CbGpPWpGaD
Aclidinium—CHRM5—GPCR ligand binding—CXCL8—Crohn's disease	0.00062	0.00107	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CCR9—Crohn's disease	0.00062	0.00107	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CCR9—Crohn's disease	0.000618	0.00107	CbGpPWpGaD
Aclidinium—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.000618	0.00107	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—PTGER4—Crohn's disease	0.000612	0.00106	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CCR9—Crohn's disease	0.000612	0.00106	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—PTGER4—Crohn's disease	0.00061	0.00106	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CCR6—Crohn's disease	0.000609	0.00105	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—GPX4—Crohn's disease	0.000605	0.00105	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—PTGER4—Crohn's disease	0.000604	0.00105	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—IL2RA—Crohn's disease	0.000597	0.00103	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—GCKR—Crohn's disease	0.000584	0.00101	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CCR6—Crohn's disease	0.000583	0.00101	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—GPR65—Crohn's disease	0.000577	0.000998	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—GPR65—Crohn's disease	0.000575	0.000995	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—IL3—Crohn's disease	0.000574	0.000994	CbGpPWpGaD
Aclidinium—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000573	0.000992	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—IL3—Crohn's disease	0.000572	0.000991	CbGpPWpGaD
Aclidinium—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000572	0.000989	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—IL2RA—Crohn's disease	0.000571	0.000989	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—GPR65—Crohn's disease	0.000569	0.000985	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—IL3—Crohn's disease	0.000567	0.000981	CbGpPWpGaD
Aclidinium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000566	0.00098	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000555	0.000961	CbGpPWpGaD
Aclidinium—CHRM2—SIDS Susceptibility Pathways—IL6—Crohn's disease	0.000555	0.000961	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000554	0.000958	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—RBX1—Crohn's disease	0.000551	0.000954	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000548	0.000949	CbGpPWpGaD
Aclidinium—BCHE—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	0.000543	0.00094	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—IL2RA—Crohn's disease	0.000542	0.000938	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—PTGER4—Crohn's disease	0.000536	0.000928	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—RBX1—Crohn's disease	0.000528	0.000913	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—IL3—Crohn's disease	0.000522	0.000902	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—IL3—Crohn's disease	0.00052	0.0009	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—IL2RA—Crohn's disease	0.000519	0.000898	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—IL3—Crohn's disease	0.000515	0.000891	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—PTGER4—Crohn's disease	0.000514	0.000889	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—RASGRP1—Crohn's disease	0.000504	0.000873	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—RASGRP1—Crohn's disease	0.000503	0.00087	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—RASGRP1—Crohn's disease	0.000498	0.000862	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—UBE2D1—Crohn's disease	0.000483	0.000836	CbGpPWpGaD
Aclidinium—BCHE—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	0.000475	0.000822	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—RIPK2—Crohn's disease	0.000469	0.000811	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—UBE2D1—Crohn's disease	0.000463	0.000801	CbGpPWpGaD
Aclidinium—CHRM1—Circadian rythm related genes—IL6—Crohn's disease	0.000459	0.000794	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—IL3—Crohn's disease	0.000457	0.000791	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—RIPK2—Crohn's disease	0.000449	0.000776	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—RASGRP1—Crohn's disease	0.000442	0.000765	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—IL3—Crohn's disease	0.000438	0.000757	CbGpPWpGaD
Aclidinium—CHRM1—GPCR ligand binding—CXCL8—Crohn's disease	0.000437	0.000756	CbGpPWpGaD
Aclidinium—CHRM3—GPCR ligand binding—CXCL8—Crohn's disease	0.000435	0.000753	CbGpPWpGaD
Aclidinium—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.000435	0.000753	CbGpPWpGaD
Aclidinium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.000434	0.00075	CbGpPWpGaD
Aclidinium—CHRM2—GPCR ligand binding—CXCL8—Crohn's disease	0.000431	0.000746	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—RASGRP1—Crohn's disease	0.000423	0.000732	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CCR6—Crohn's disease	0.000411	0.000711	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CCR6—Crohn's disease	0.00041	0.000709	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CCR6—Crohn's disease	0.000406	0.000702	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—IL2RA—Crohn's disease	0.000402	0.000696	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—JAK2—Crohn's disease	0.000401	0.000694	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—IL2RA—Crohn's disease	0.000401	0.000694	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—SOCS1—Crohn's disease	0.0004	0.000693	CbGpPWpGaD
Aclidinium—BCHE—Metabolism of proteins—CXCL8—Crohn's disease	0.000398	0.000689	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—IL2RA—Crohn's disease	0.000397	0.000687	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—JAK2—Crohn's disease	0.000384	0.000665	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—SOCS1—Crohn's disease	0.000383	0.000663	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—TYK2—Crohn's disease	0.000382	0.000661	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—RBX1—Crohn's disease	0.000372	0.000643	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—RBX1—Crohn's disease	0.00037	0.000641	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—RBX1—Crohn's disease	0.000367	0.000635	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—CXCL8—Crohn's disease	0.000366	0.000633	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—TYK2—Crohn's disease	0.000366	0.000633	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—IL2RA—Crohn's disease	0.000365	0.000632	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—JAK2—Crohn's disease	0.000364	0.00063	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—IL2RA—Crohn's disease	0.000364	0.00063	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—PTGER4—Crohn's disease	0.000362	0.000626	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—IL2RA—Crohn's disease	0.000361	0.000624	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—PTGER4—Crohn's disease	0.000361	0.000624	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—PTGER4—Crohn's disease	0.000357	0.000618	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—CXCL8—Crohn's disease	0.000351	0.000607	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—JAK2—Crohn's disease	0.000349	0.000603	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—SMAD3—Crohn's disease	0.000346	0.000598	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—CXCL8—Crohn's disease	0.000332	0.000575	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—SMAD3—Crohn's disease	0.000331	0.000573	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—UBE2D1—Crohn's disease	0.000326	0.000564	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—UBE2D1—Crohn's disease	0.000325	0.000562	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—UBE2D1—Crohn's disease	0.000322	0.000557	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—IL2RA—Crohn's disease	0.00032	0.000554	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—CXCL8—Crohn's disease	0.000318	0.000551	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—RIPK2—Crohn's disease	0.000316	0.000547	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—RIPK2—Crohn's disease	0.000315	0.000545	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—RIPK2—Crohn's disease	0.000312	0.00054	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—IL3—Crohn's disease	0.000308	0.000533	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—IL3—Crohn's disease	0.000307	0.000531	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—IL2RA—Crohn's disease	0.000307	0.00053	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—IL3—Crohn's disease	0.000304	0.000526	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—RASGRP1—Crohn's disease	0.000298	0.000516	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—RASGRP1—Crohn's disease	0.000297	0.000514	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—RASGRP1—Crohn's disease	0.000294	0.000509	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—JAK2—Crohn's disease	0.00027	0.000468	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—SOCS1—Crohn's disease	0.00027	0.000467	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—JAK2—Crohn's disease	0.00027	0.000466	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—SOCS1—Crohn's disease	0.000269	0.000466	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—JAK2—Crohn's disease	0.000267	0.000462	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—SOCS1—Crohn's disease	0.000266	0.000461	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—TYK2—Crohn's disease	0.000257	0.000445	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—TYK2—Crohn's disease	0.000257	0.000444	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—TYK2—Crohn's disease	0.000254	0.00044	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—CXCL8—Crohn's disease	0.000247	0.000427	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—CXCL8—Crohn's disease	0.000246	0.000426	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—JAK2—Crohn's disease	0.000246	0.000425	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—JAK2—Crohn's disease	0.000245	0.000424	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—CXCL8—Crohn's disease	0.000244	0.000422	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—JAK2—Crohn's disease	0.000242	0.000419	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—ALB—Crohn's disease	0.000242	0.000419	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—SMAD3—Crohn's disease	0.000233	0.000403	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—SMAD3—Crohn's disease	0.000232	0.000402	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—SMAD3—Crohn's disease	0.00023	0.000398	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—TYK2—Crohn's disease	0.000226	0.00039	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—CXCL8—Crohn's disease	0.000224	0.000388	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—CXCL8—Crohn's disease	0.000223	0.000387	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—CXCL8—Crohn's disease	0.000221	0.000383	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—TYK2—Crohn's disease	0.000216	0.000374	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—IL2RA—Crohn's disease	0.000216	0.000373	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—JAK2—Crohn's disease	0.000215	0.000372	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—IL2RA—Crohn's disease	0.000215	0.000372	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—IL2RA—Crohn's disease	0.000213	0.000369	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—PTGS2—Crohn's disease	0.000212	0.000366	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—JAK2—Crohn's disease	0.000206	0.000357	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CXCL8—Crohn's disease	0.000196	0.00034	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CXCL8—Crohn's disease	0.000188	0.000325	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—IL6—Crohn's disease	0.000187	0.000323	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—ALB—Crohn's disease	0.000186	0.000322	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—IL6—Crohn's disease	0.000179	0.000309	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—PTGS2—Crohn's disease	0.000163	0.000282	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—STAT3—Crohn's disease	0.000158	0.000273	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—TYK2—Crohn's disease	0.000152	0.000263	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—TYK2—Crohn's disease	0.000152	0.000262	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—STAT3—Crohn's disease	0.000151	0.000262	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—TYK2—Crohn's disease	0.00015	0.00026	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—JAK2—Crohn's disease	0.000145	0.000251	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—JAK2—Crohn's disease	0.000145	0.00025	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—JAK2—Crohn's disease	0.000143	0.000248	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CXCL8—Crohn's disease	0.000132	0.000229	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CXCL8—Crohn's disease	0.000132	0.000228	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CXCL8—Crohn's disease	0.000131	0.000226	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—IL6—Crohn's disease	0.000126	0.000218	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—IL6—Crohn's disease	0.000125	0.000217	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—IL6—Crohn's disease	0.000124	0.000215	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—IL6—Crohn's disease	0.00011	0.000191	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—STAT3—Crohn's disease	0.000106	0.000184	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—STAT3—Crohn's disease	0.000106	0.000184	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—IL6—Crohn's disease	0.000106	0.000183	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—STAT3—Crohn's disease	0.000105	0.000182	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—IL6—Crohn's disease	7.44e-05	0.000129	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—IL6—Crohn's disease	7.41e-05	0.000128	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—IL6—Crohn's disease	7.34e-05	0.000127	CbGpPWpGaD
